Due to the pronounced role of BRCA1 and BRCA2 in hereditary breast and ovarian cancer, different mutations and variants of BARD1 were first investigated in breast cancers and various gynecological cancers in the late 1990s and early 2000s [10,11,12]. The gene discussed is BRCA1; the disease is female reproductive organ cancer.